feat(depmap): publish and wire DepMap Public 26Q1 evidence - #75
Merged
Merged
Conversation
Publish the sanitized real DepMap Public 26Q1 evidence bundle and integrate it into the v0.5.0 reporting workflow. Add portable release loading, reproducibility metadata, checksums, inventories, 331 Markdown cards, 331 HTML reports, the discovery overlay, and authoritative three-intent baseline rankings. Preserve the deterministic 300-target baseline and keep DepMap as an optional post-ranking research-preview evidence layer requiring human review. Closes #74.
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment
1 participant
Add this suggestion to a batch that can be applied as a single commit.This suggestion is invalid because no changes were made to the code.Suggestions cannot be applied while the pull request is closed.Suggestions cannot be applied while viewing a subset of changes.Only one suggestion per line can be applied in a batch.Add this suggestion to a batch that can be applied as a single commit.Applying suggestions on deleted lines is not supported.You must change the existing code in this line in order to create a valid suggestion.Outdated suggestions cannot be applied.This suggestion has been applied or marked resolved.Suggestions cannot be applied from pending reviews.Suggestions cannot be applied on multi-line comments.Suggestions cannot be applied while the pull request is queued to merge.Suggestion cannot be applied right now. Please check back later.
Summary
Completes TargetIntel-IO Issue 512 and closes the v0.5.0 DepMap Public 26Q1 publication workflow.
Validation
git diff --checkpassedScientific boundaries
DepMap cell-line dependency is not interpreted as clinical anti-PD-1 response evidence. Lack of tumor-cell dependency does not invalidate immune targets, and discovery-only identities are not promoted into the productive baseline.
Closes #74